Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hacene

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|March 1, 1992
Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinomaP Bougnoux, V Chajes, M Lanson, et al.
Bulletin Du Cancer|January 1, 1990
[Long-term results of radio-surgical treatment of operable carcinoma of the cervix uteri]S Lasry, C Cohen-Solal, K Hacene, et al.
Gynecologic Oncology|March 11, 2008
Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric studyJ M Riedinger, N Eche, J P Basuyau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Management and clinical outcomes of pregnant patients with invasive cervical cancerN Germann, C Haie-Meder, P Morice, et al.
Anticancer Research|May 4, 2005
Tissue expression and serum levels of the oncoprotein HER-2/neu in 157 primary breast tumoursC Pallud, J M Guinebretiere, S Guepratte, et al.
Bulletin Du Cancer|January 1, 1985
[Cancer of the prostate. Epidemiologic evaluation, incidence, and trends, especially in France]J Berlie, A Rezvani, K Hacene, et al.
Cancer|April 15, 1992
Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors, and normal breast tissues. Correlation with prognosis and adjuvant hormone therapyJ Predine, F Spyratos, J F Prud'homme, et al.
Bulletin Du Cancer|January 1, 1987
[An expert system of aiding decision making in breast pathology connected to a clinical data base]M Brunet, S Durrleman, J Ferber, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin DJ P Brouillet, F Spyratos, K Hacene, et al.
In Vivo (Athens, Greece)|May 7, 2005
Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculographyM F Pichon, F Cvitkovic, K Hacene, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|March 1, 1992
Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinomaP Bougnoux, V Chajes, M Lanson, et al.
Bulletin Du Cancer|January 1, 1990
[Long-term results of radio-surgical treatment of operable carcinoma of the cervix uteri]S Lasry, C Cohen-Solal, K Hacene, et al.
Gynecologic Oncology|March 11, 2008
Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric studyJ M Riedinger, N Eche, J P Basuyau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Management and clinical outcomes of pregnant patients with invasive cervical cancerN Germann, C Haie-Meder, P Morice, et al.
Anticancer Research|May 4, 2005
Tissue expression and serum levels of the oncoprotein HER-2/neu in 157 primary breast tumoursC Pallud, J M Guinebretiere, S Guepratte, et al.
Bulletin Du Cancer|January 1, 1985
[Cancer of the prostate. Epidemiologic evaluation, incidence, and trends, especially in France]J Berlie, A Rezvani, K Hacene, et al.
Cancer|April 15, 1992
Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors, and normal breast tissues. Correlation with prognosis and adjuvant hormone therapyJ Predine, F Spyratos, J F Prud'homme, et al.
Bulletin Du Cancer|January 1, 1987
[An expert system of aiding decision making in breast pathology connected to a clinical data base]M Brunet, S Durrleman, J Ferber, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin DJ P Brouillet, F Spyratos, K Hacene, et al.
In Vivo (Athens, Greece)|May 7, 2005
Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculographyM F Pichon, F Cvitkovic, K Hacene, et al.
Pageof 5